Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

AIS PAINCARE — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

AIS PAINCARE

via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ

2nd Quarter (Apr 1 - June 30) · 2019Posted Jul 14, 2019Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: AIS PAINCARE
Description: Specialty pharmacy services
Location: Mississippi · United States of America

Registrant

Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Description: Law firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medicare/Medicaid
Opioid management.
LobbyistsJENNIFER SUMMA · NICOLE CARELLI
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.